Amy H. Case
Expertise in
11
conditions

Dr. Amy H. Case

Intensive Care Medicine | Pulmonary Medicine
275 Collier Road NW, Suite 300, 
Atlanta, GA 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
11
conditions
275 Collier Road NW, Suite 300, 
Atlanta, GA 

Overview

Amy Hajari Case, M.D., FCCP, received her undergraduate degree from Birmingham-Southern College and earned her medical degree from the University of Alabama at Birmingham in 2005. She completed her internal medicine residency and pulmonary and critical care medicine fellowship at the University of Alabama at Birmingham. Prior to joining Piedmont Physicians, Dr. Hajari Case was in practice with Georgia Lung Associates. She holds board certifications in critical care medicine, pulmonary disease and internal medicine. She is a member of the American Thoracic Society and a fellow of the American College of Chest Physicians. Dr. Hajari Case specializes in the diagnosis and management of patients with interstitial lung diseases. She leads a monthly support group for patients with pulmonary fibrosis in Austell, and she is on the steering committee for the ACCP Interstitial and Diffuse Lung Disease NetWork. She is the Director of the Interstitial Lung Disease Program and Research department at Piedmont Physicians Georgia Lung. Dr. Hajari Case enjoys bringing her patients the opportunity to receive new medications and cutting edge treatments. She is also interested in medical education and leads a bi-monthly pulmonary and critical care journal club meeting. In her spare time, Dr. Hajari Case enjoys traveling, listening to live music, and musical theatre. Dr. Hajari Case welcomes new patients and accepts most insurance plans.

Dr. Case is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Lung Transplant, and Gastrostomy.

Dr. Case is board certified in American Board Of Internal Medicine - Pulmonary Disease and American Board Of Internal Medicine - Critical Care Medicine. She is actively involved in clinical research, co-authoring 21 peer reviewed articles and participating in 10 clinical trials. Dr. Case is currently accepting new patients.

Specialties

Intensive Care Medicine
Pulmonary Medicine

Licenses

Internal Medicine in GA

Board Certifications

American Board Of Internal Medicine - Pulmonary Disease
American Board Of Internal Medicine - Critical Care Medicine

Fellowships

University of Alabama at Birmingham, Pulmonary Medicine, 2011

Hospital Affiliations

Piedmont Mountainside Hospital Inc
Piedmont Newnan Hospital, Inc
Piedmont Hospital, Inc
Wellstar Kennestone Regional Medical Center
Piedmont Fayette Hospital

Languages Spoken

English
Bulgarian
French
Mandarin

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Piedmont Physicians Pulmonary and Sleep Medicine Buckhead
275 Collier Road NW, Suite 300, Atlanta, GA 30309

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
A Prospective, Randomized, Controlled Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Spiration® Valve System for the Single Lobe Treatment of Severe Emphysema
A Prospective, Randomized, Controlled Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Spiration® Valve System for the Single Lobe Treatment of Severe Emphysema
Enrollment Status: Completed
Publish Date: May 31, 2024
Intervention Type: Other, Device
Study Phase: Not Applicable
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Dose Escalation and Verification Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide (iNO) in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2) - REBUILD
A Randomized, Double-Blind, Placebo-Controlled Dose Escalation and Verification Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide (iNO) in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2) - REBUILD
Enrollment Status: Terminated
Publish Date: July 27, 2023
Intervention Type: Combination product
Study Drug: INOpulse
Study Phase: Phase 3
Pulmonary Fibrosis Foundation Patient Registry
Pulmonary Fibrosis Foundation Patient Registry
Enrollment Status: Completed
Publish Date: July 07, 2023
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)
A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)
Enrollment Status: Completed
Publish Date: December 14, 2021
Intervention Type: Drug
Study Phase: Phase 2
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Enrollment Status: Completed
Publish Date: February 15, 2021
Intervention Type: Other
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 9 Less Clinical Trials

21 Total Publications

Deupirfenidone compared with pirfenidone and placebo in idiopathic pulmonary fibrosis (ELEVATE-IPF): a phase 2b randomized placebo-controlled trial.
Deupirfenidone compared with pirfenidone and placebo in idiopathic pulmonary fibrosis (ELEVATE-IPF): a phase 2b randomized placebo-controlled trial.
Journal: American journal of respiratory and critical care medicine
Published: December 12, 2025
Similar Doctors
Expertise in
15
conditions
Dr. Srihari Veeraraghavan
Pulmonary Medicine
Expertise in
15
conditions
Dr. Srihari Veeraraghavan
Pulmonary Medicine
Referral may be required
Before you request

Emory Clinic At 1365 Clifton Road

1365 Clifton Road Northeast, BldgA, 
Atlanta, GA 
 (3.5 miles away)
404-778-3261
Languages Spoken:
English, Hindi, Spanish, Tamil
See accepted insurances
Accepting New Patients
Offers Telehealth

Srihari Veeraraghavan is a Pulmonary Medicine provider practicing medicine in Atlanta, Georgia. Dr. Veeraraghavan is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, Sarcoidosis, and Lung Transplant. Dr. Veeraraghavan is board certified in American Board Of Internal Medicine, 1999. Dr. Veeraraghavan is currently accepting new patients.

Expertise in
28
conditions
Dr. Alexander Gluzman
Pulmonary Medicine | Intensive Care Medicine
Expertise in
28
conditions
Dr. Alexander Gluzman
Pulmonary Medicine | Intensive Care Medicine
Referral may be required
Before you request

Piedmont Physicians Pulmonary And Sleep Medicine Buckhead

275 Collier Road NW, Suite 300, 
Atlanta, GA 
 (0.1 miles away)
404-350-0009
Languages Spoken:
English, Bulgarian, French, Mandarin, Russian
See accepted insurances
Accepting New Patients
Offers Telehealth

Alexander Gluzman, M.D., earned his medical degree from Medical College of Georgia in Augusta, Ga. He completed his residency and pulmonary and criticalcare training at Emory University. He received his undergraduate degree from Emory University. Prior to joining Piedmont Physicians, Dr. Gluzman was in practice with Georgia Lung Associates. Dr. Gluzman has been practicing medicine for 10 years. He holdsboard certifications in critical care medicine, pulmonary disease and internal medicine. Dr. Gluzman specializes in advanced bronchoscopy techniques such as EBUS and electromagnetic navigational bronchoscopy. He will be providing intensive care coverage at Piedmont Atlanta, and is fluent in Russian. In his spare time, Dr. Gluzman enjoys spending time with family, reading and traveling. Dr. Gluzman welcomes new patients and accepts most insurance plans. Dr. Gluzman is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Lung Metastases, Bronchogenic Cyst, Pneumonia, Gastrostomy, and Advanced Bronchoscopy. Dr. Gluzman is board certified in American Board Of Internal Medicine - Pulmonary Disease, American Board Of Internal Medicine, and American Board Of Internal Medicine - Critical Care Medicine. Dr. Gluzman is currently accepting new patients.

Expertise in
14
conditions
Dr. Jermaine M. Jackson
Pulmonary Medicine | Intensive Care Medicine
Expertise in
14
conditions
Dr. Jermaine M. Jackson
Pulmonary Medicine | Intensive Care Medicine
Referral may be required
Before you request

Piedmont Physicians Pulmonary And Sleep Medicine Buckhead

275 Collier Road NW, Suite 300, 
Atlanta, GA 
 (0.1 miles away)
404-350-0009
Languages Spoken:
English, Bulgarian, French, Mandarin
See accepted insurances
Accepting New Patients
Offers Telehealth

Jermaine M. Jackson, M.D., FCCP, graduated summa cum laude with a bachelor of science in biology from Tennessee State University in Nashville. He earned his medical degree from the University of Tennessee College of Medicine in Memphis. He completed his residency in internal medicine and was subsequently chief resident at Riverside Methodist Hospital in Columbus, Ohio. Dr. Jackson completed his fellowship in pulmonary and critical care medicine at Duke University Medical Center in Durham, N.C. Prior to joining Piedmont Physicians, Dr. Jackson was in practice with Georgia Lung Associates.Dr. Jackson holds board certifications in critical care medicine, pulmonary medicine and internal medicine. He is a member of the Society of Critical Care Medicine and a fellow of the American College of Chest Physicians. Dr. Jackson's philosophy of medicine begins with empathy, compassion and competency. He adheres firmly to the belief that patients should always come first. His charisma and tenacity make him highly regarded by patients and colleagues alike.Dr. Jackson welcomes new patients and accepts most insurance plans. Dr. Jackson is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Neurosarcoidosis, Sarcoidosis, Lung Metastases, Pneumonia, and Gastrostomy. Dr. Jackson is board certified in American Board Of Internal Medicine - Pulmonary Disease and American Board Of Internal Medicine - Critical Care Medicine. Dr. Jackson is currently accepting new patients.

Frequently Asked Questions about Dr. Amy H. Case

How do I make an appointment with Dr. Amy H. Case?

You can book an appointment with Dr. Amy H. Case by calling their office at 404-350-0009. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Amy H. Case a top-rated expert for Acute Interstitial Pneumonia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Amy H. Case is classified as an Elite expert for Acute Interstitial Pneumonia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Amy H. Case specialize in?

While Dr. Amy H. Case is a Intensive Care Medicine, they have specific expertise in Acute Interstitial Pneumonia, Interstitial Lung Disease, and Idiopathic Pulmonary Fibrosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Intensive Care Medicine.

Does Dr. Amy H. Case participate in research or clinical trials?

Yes. Dr. Amy H. Case has published 21 articles and abstracts on conditions like Acute Interstitial Pneumonia. You can view a list of Dr. Amy H. Case's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Amy H. Case accept my insurance?

Dr. Amy H. Case accepts most major insurance plans, including Aetna and Alliant Health. We recommend calling the office directly at 404-350-0009 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Case's expertise for a condition
ConditionClose
View All 45 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile